Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11316542rdf:typepubmed:Citationlld:pubmed
pubmed-article:11316542lifeskim:mentionsumls-concept:C0013216lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0684249lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0441771lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0680190lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0280617lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C1831915lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0332173lld:lifeskim
pubmed-article:11316542lifeskim:mentionsumls-concept:C0205420lld:lifeskim
pubmed-article:11316542pubmed:issue1lld:pubmed
pubmed-article:11316542pubmed:dateCreated2001-4-24lld:pubmed
pubmed-article:11316542pubmed:abstractTextTo investigate whether the addition of weekend chemotherapy consisting of carboplatin/etoposide to hyperfractionated radiation therapy (Hfx RT) and concurrent daily carboplatin/etoposide offers an advantage over the same Hfx RT/daily carboplatin/etoposide.lld:pubmed
pubmed-article:11316542pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316542pubmed:languageenglld:pubmed
pubmed-article:11316542pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316542pubmed:citationSubsetIMlld:pubmed
pubmed-article:11316542pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316542pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11316542pubmed:statusMEDLINElld:pubmed
pubmed-article:11316542pubmed:monthMaylld:pubmed
pubmed-article:11316542pubmed:issn0360-3016lld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:JeremicBBlld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:ShibamotoYYlld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:Radosavljevic...lld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:AcimovicLLlld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:Milisavljevic...lld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:MilicicBBlld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:NikolicNNlld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:Aleksandrovic...lld:pubmed
pubmed-article:11316542pubmed:authorpubmed-author:DagovicAAlld:pubmed
pubmed-article:11316542pubmed:issnTypePrintlld:pubmed
pubmed-article:11316542pubmed:day1lld:pubmed
pubmed-article:11316542pubmed:volume50lld:pubmed
pubmed-article:11316542pubmed:ownerNLMlld:pubmed
pubmed-article:11316542pubmed:authorsCompleteYlld:pubmed
pubmed-article:11316542pubmed:pagination19-25lld:pubmed
pubmed-article:11316542pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:meshHeadingpubmed-meshheading:11316542...lld:pubmed
pubmed-article:11316542pubmed:year2001lld:pubmed
pubmed-article:11316542pubmed:articleTitleHyperfractionated radiation therapy and concurrent low-dose, daily carboplatin/etoposide with or without weekend carboplatin/etoposide chemotherapy in stage III non-small-cell lung cancer: a randomized trial.lld:pubmed
pubmed-article:11316542pubmed:affiliationDepartment of Oncology, University Hospital, Kragujevac, Yugoslavia. bjeremic@med.uni-tuebingen.delld:pubmed
pubmed-article:11316542pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11316542pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:11316542pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:11316542pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11316542lld:pubmed